Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Pompe Care Podcast Series 2

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

4.4. Dr. Bakó Barnabás 1 - Mit kell tudnunk a szenzorokról?

1.5. Dr. Chmel Rita – Mi az a C-peptid?

Dupixent COPD korvattavuuskriteerit

Structured Monitoring for Early Detection of Fabry Progression

Structured Monitoring for Early Detection of Fabry Progression

Structured Monitoring for Early Detection of Fabry Progression

Structured Monitoring for Early Detection of Fabry Progression

Typ-2 Identifizierung Fragebogen multidisziplinär

Webinar Gaucher: recunoastere la timp, diagnostic corect, speranta pentru pacienti.